Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Liss

Showing results (231-240 of 256) with videos related to

Pageof 26
Sort By:
The Journal of Urology|April 30, 2025
Magnetic Resonance Imaging at Second Surveillance Biopsy After Diagnosis in Patients With Grade Group 1 Prostate Cancer in the Canary Prostate Active Surveillance StudyMeera R Chappidi, Lisa F Newcomb, Yingye Zheng, et al.
International Journal of Radiation Oncology, Biology, Physics|March 28, 2025
Multidisciplinary Consensus Prostate Contours on Magnetic Resonance Imaging: Educational Atlas and Reference Standard for Artificial Intelligence BenchmarkingYuze Song, Anna M Dornisch, Robert T Dess, et al.
Abdominal Radiology (New York)|February 25, 2016
Restriction spectrum imaging improves MRI-based prostate cancer detectionKevin C McCammack, Natalie M Schenker-Ahmed, Nathan S White, et al.
Frontiers in Oncology|March 6, 2015
MRI-Derived Restriction Spectrum Imaging Cellularity Index is Associated with High Grade Prostate Cancer on Radical Prostatectomy SpecimensMichael A Liss, Nathan S White, J Kellogg Parsons, et al.
European Urology|February 19, 2013
Laparoendoscopic single-site partial nephrectomy: a multi-institutional outcome analysisFrancesco Greco, Riccardo Autorino, Koon H Rha, et al.
JAMA|May 30, 2024
Long-Term Outcomes in Patients Using Protocol-Directed Active Surveillance for Prostate CancerLisa F Newcomb, Jeannette M Schenk, Yingye Zheng, et al.
The Lancet. Oncology|June 1, 2026
Aglatimagene besadenovec (CAN-2409) with radiotherapy for patients with localised prostate cancer: a phase 3, multicentre, randomised, double-blind, placebo-controlled trialTheodore L DeWeese, Andrea Manzanera, John Sylvester, et al.
Cancer Medicine|April 25, 2022
Germline mutations in penetrant cancer predisposition genes are rare in men with prostate cancer selecting active surveillanceLauren Brady, Lisa F Newcomb, Kehao Zhu, et al.
European Urology Oncology|November 15, 2024
Colibactin Exerts Androgen-dependent and -independent Effects on Prostate CancerRaag Agrawal, Sarah Al-Hiyari, Rupert Hugh-White, et al.
Clinical Genitourinary Cancer|July 1, 2020
Oncologic and Functional Outcomes of Radical and Partial Nephrectomy in pT3a Pathologically Upstaged Renal Cell Carcinoma: A Multi-institutional AnalysisSunil H Patel, Robert G Uzzo, Alessandro Larcher, et al.
Pageof 26

Showing results (231-240 of 256) with videos related to

Sort By:
Pageof 26
The Journal of Urology|April 30, 2025
Magnetic Resonance Imaging at Second Surveillance Biopsy After Diagnosis in Patients With Grade Group 1 Prostate Cancer in the Canary Prostate Active Surveillance StudyMeera R Chappidi, Lisa F Newcomb, Yingye Zheng, et al.
International Journal of Radiation Oncology, Biology, Physics|March 28, 2025
Multidisciplinary Consensus Prostate Contours on Magnetic Resonance Imaging: Educational Atlas and Reference Standard for Artificial Intelligence BenchmarkingYuze Song, Anna M Dornisch, Robert T Dess, et al.
Abdominal Radiology (New York)|February 25, 2016
Restriction spectrum imaging improves MRI-based prostate cancer detectionKevin C McCammack, Natalie M Schenker-Ahmed, Nathan S White, et al.
Frontiers in Oncology|March 6, 2015
MRI-Derived Restriction Spectrum Imaging Cellularity Index is Associated with High Grade Prostate Cancer on Radical Prostatectomy SpecimensMichael A Liss, Nathan S White, J Kellogg Parsons, et al.
European Urology|February 19, 2013
Laparoendoscopic single-site partial nephrectomy: a multi-institutional outcome analysisFrancesco Greco, Riccardo Autorino, Koon H Rha, et al.
JAMA|May 30, 2024
Long-Term Outcomes in Patients Using Protocol-Directed Active Surveillance for Prostate CancerLisa F Newcomb, Jeannette M Schenk, Yingye Zheng, et al.
The Lancet. Oncology|June 1, 2026
Aglatimagene besadenovec (CAN-2409) with radiotherapy for patients with localised prostate cancer: a phase 3, multicentre, randomised, double-blind, placebo-controlled trialTheodore L DeWeese, Andrea Manzanera, John Sylvester, et al.
Cancer Medicine|April 25, 2022
Germline mutations in penetrant cancer predisposition genes are rare in men with prostate cancer selecting active surveillanceLauren Brady, Lisa F Newcomb, Kehao Zhu, et al.
European Urology Oncology|November 15, 2024
Colibactin Exerts Androgen-dependent and -independent Effects on Prostate CancerRaag Agrawal, Sarah Al-Hiyari, Rupert Hugh-White, et al.
Clinical Genitourinary Cancer|July 1, 2020
Oncologic and Functional Outcomes of Radical and Partial Nephrectomy in pT3a Pathologically Upstaged Renal Cell Carcinoma: A Multi-institutional AnalysisSunil H Patel, Robert G Uzzo, Alessandro Larcher, et al.
Pageof 26